|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The 10th largest pharmaceutical company in the world, Lilly has remained dedicated to creating medicines that help improve peoples' quality of life for more than 135 years. At the heart of Lilly's operations are its core values - excellence, integrity and respect for people.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
How Lilly conducts its business is equally as important as the work it does on a daily basis. Lilly's core values - integrity, excellence and respect for people - are reflected in business practices that include strong governance principles, the ethical development of medicines, transparency and ethical product promotion.
|
|
|
|
|
|
|
Lilly's innovative products focus on meeting medical needs in the fields of oncology, cardiovascular, diabetes, critical care, neuroscience, men's health and musculoskeletal. Additionally, Elanco, a division of Eli Lilly and Company, works to provide an equally high standard of quality care and product development for animals.
|
|
|
|
|
|
|
|
|
|
|
More than 7,300 people comprise Lilly Research Laboratories (LRL), which operates in more than 50 countries worldwide. LRL works to discover and develop innovative therapies for many of the world's unmet medical needs, while also providing ongoing scientific support for marketed products.
TODAY'S DATE: May 25, 2013
Lilly Oncology to Release New Pipeline Data at ASCO 2013
Lilly Provides Update on CEO Dr. John Lechleiter
Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery
